
Frankie L. Stinson
Examiner (ID: 8117)
| Most Active Art Unit | 1746 |
| Art Unit(s) | 1792, 1711, 2402, 1746, 2899, 3405, 1743 |
| Total Applications | 3621 |
| Issued Applications | 3013 |
| Pending Applications | 138 |
| Abandoned Applications | 470 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 12177351
[patent_doc_number] => 20180036287
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'BENZOTHIAZOLE AND BENZOTHIOPHENE COMPOUNDS'
[patent_app_type] => utility
[patent_app_number] => 15/549307
[patent_app_country] => US
[patent_app_date] => 2016-02-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 36567
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15549307
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/549307 | Benzothiazole and benzothiophene compounds | Feb 24, 2016 | Issued |
Array
(
[id] => 11612529
[patent_doc_number] => 09650378
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-16
[patent_title] => '(1-azinone)-substituted pyridoindoles'
[patent_app_type] => utility
[patent_app_number] => 15/045652
[patent_app_country] => US
[patent_app_date] => 2016-02-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 101730
[patent_no_of_claims] => 41
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15045652
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/045652 | (1-azinone)-substituted pyridoindoles | Feb 16, 2016 | Issued |
Array
(
[id] => 12183995
[patent_doc_number] => 20180042931
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-15
[patent_title] => 'N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS'
[patent_app_type] => utility
[patent_app_number] => 15/552251
[patent_app_country] => US
[patent_app_date] => 2016-02-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42611
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15552251
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/552251 | N-PHENYL-(MORPHOLIN-4-YL OR PIPERAZINYL)ACETAMIDE DERIVATIVES AND THEIR USE AS INHIBITORS OF THE WNT SIGNALLING PATHWAYS | Feb 15, 2016 | Abandoned |
Array
(
[id] => 12178659
[patent_doc_number] => 20180037595
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'BENZOXABOROLE COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/550658
[patent_app_country] => US
[patent_app_date] => 2016-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 35537
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15550658
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/550658 | BENZOXABOROLE COMPOUNDS AND USES THEREOF | Feb 11, 2016 | Abandoned |
Array
(
[id] => 10812075
[patent_doc_number] => 20160158234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'BIHETEROARYL COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/041375
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45709
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041375 | Biheteroaryl compounds and uses thereof | Feb 10, 2016 | Issued |
Array
(
[id] => 10812075
[patent_doc_number] => 20160158234
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'BIHETEROARYL COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/041375
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45709
[patent_no_of_claims] => 42
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15041375
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/041375 | Biheteroaryl compounds and uses thereof | Feb 10, 2016 | Issued |
Array
(
[id] => 11038794
[patent_doc_number] => 20160235750
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-08-18
[patent_title] => 'SMALL MOLECULES TARGETING HIV-1 NEF'
[patent_app_type] => utility
[patent_app_number] => 15/042069
[patent_app_country] => US
[patent_app_date] => 2016-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 8205
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15042069
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/042069 | Small molecules targeting HIV-1 Nef | Feb 10, 2016 | Issued |
Array
(
[id] => 12086773
[patent_doc_number] => 09840491
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-12-12
[patent_title] => 'Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors'
[patent_app_type] => utility
[patent_app_number] => 15/015571
[patent_app_country] => US
[patent_app_date] => 2016-02-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 40681
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 6
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15015571
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/015571 | Quinazolinones and azaquinazolinones as ubiquitin-specific protease 7 inhibitors | Feb 3, 2016 | Issued |
Array
(
[id] => 12178643
[patent_doc_number] => 20180037580
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-02-08
[patent_title] => 'Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof'
[patent_app_type] => utility
[patent_app_number] => 15/548158
[patent_app_country] => US
[patent_app_date] => 2016-02-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18331
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15548158
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/548158 | Substituted pyrazolo[1,5-a]-pyridine-3-carboxamides and use thereof | Feb 1, 2016 | Issued |
Array
(
[id] => 10782848
[patent_doc_number] => 20160129004
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-05-12
[patent_title] => 'SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE'
[patent_app_type] => utility
[patent_app_number] => 14/996678
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16813
[patent_no_of_claims] => 12
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14996678
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/996678 | SUBSTITUTED 5-FLUORO-1H-PYRAZOLOPYRIDINES AND THEIR USE | Jan 14, 2016 | Abandoned |
Array
(
[id] => 12641031
[patent_doc_number] => 20180105508
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-04-19
[patent_title] => INHIBITORS OF PHOSPHOGLYCERATE DEHYDROGENASE (PHGDH) AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/543643
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44657
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15543643
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/543643 | Inhibitors of phosphoglycerate dehydrogenase (PHGDH) and uses thereof | Jan 14, 2016 | Issued |
Array
(
[id] => 14516321
[patent_doc_number] => 10335394
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-07-02
[patent_title] => Processes for preparing dolutegravir and cabotegravir and analogues thereof
[patent_app_type] => utility
[patent_app_number] => 15/542756
[patent_app_country] => US
[patent_app_date] => 2016-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18660
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15542756
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/542756 | Processes for preparing dolutegravir and cabotegravir and analogues thereof | Jan 14, 2016 | Issued |
Array
(
[id] => 13698179
[patent_doc_number] => 20170360044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-12-21
[patent_title] => CARBAMATE COMPOUND AND USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 15/541832
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7291
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 85
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541832
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541832 | Carbamate compound and use thereof | Jan 4, 2016 | Issued |
Array
(
[id] => 12118704
[patent_doc_number] => 20180002291
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-01-04
[patent_title] => 'CARBAMATE COMPOUND AND USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 15/541882
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9298
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15541882
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/541882 | Carbamate compound and use thereof | Jan 4, 2016 | Issued |
Array
(
[id] => 16681666
[patent_doc_number] => 10941132
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-03-09
[patent_title] => Pyrazole derivatives
[patent_app_type] => utility
[patent_app_number] => 16/068272
[patent_app_country] => US
[patent_app_date] => 2016-01-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 44519
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068272
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068272 | Pyrazole derivatives | Jan 4, 2016 | Issued |
Array
(
[id] => 12546192
[patent_doc_number] => 10011604
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-03
[patent_title] => Method of treatment using substituted imidazo[1,2b]pyridazine compounds
[patent_app_type] => utility
[patent_app_number] => 14/984353
[patent_app_country] => US
[patent_app_date] => 2015-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11703
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14984353
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/984353 | Method of treatment using substituted imidazo[1,2b]pyridazine compounds | Dec 29, 2015 | Issued |
Array
(
[id] => 11001768
[patent_doc_number] => 20160198716
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-07-14
[patent_title] => 'Method for Producing Emulsifiable Pesticide Solutions'
[patent_app_type] => utility
[patent_app_number] => 14/982534
[patent_app_country] => US
[patent_app_date] => 2015-12-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6721
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14982534
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/982534 | Method for producing emulsifiable pesticide solutions | Dec 28, 2015 | Issued |
Array
(
[id] => 10812013
[patent_doc_number] => 20160158172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-06-09
[patent_title] => 'PYRAZOLOPYRIDAZINES AND METHODS FOR TREATING RETINAL-DEGENERATIVE DISEASES AND HEARING LOSS ASSOCIATED WITH USHER SYNDROME'
[patent_app_type] => utility
[patent_app_number] => 14/980347
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 25727
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14980347
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/980347 | Pyrazolopyridazines and methods for treating retinal-degenerative diseases and hearing loss associated with usher syndrome | Dec 27, 2015 | Issued |
Array
(
[id] => 10769020
[patent_doc_number] => 20160115176
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2016-04-28
[patent_title] => 'CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 14/981105
[patent_app_country] => US
[patent_app_date] => 2015-12-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 52324
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14981105
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/981105 | Crystalline forms of therapeutic compounds and uses thereof | Dec 27, 2015 | Issued |
Array
(
[id] => 14294325
[patent_doc_number] => 10287278
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-05-14
[patent_title] => Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies
[patent_app_type] => utility
[patent_app_number] => 15/539590
[patent_app_country] => US
[patent_app_date] => 2015-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 10545
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 892
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15539590
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/539590 | Chemokine CXCR1 and CXCR2 receptor antagonist compounds, and use thereof in the treatment of chemokine-mediated pathologies | Dec 21, 2015 | Issued |